Trials / Completed
CompletedNCT04789291
A Study in Healthy Men to Test How BI 1595043 is Taken up in the Body When Given With or Without Food
A Randomised, Open-label, Single-dose, Two-way Cross-over Relative Bioavailability Comparison of BI 1595043 as Tablets With and Without Food in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The main objective of this trial is to investigate the relative bioavailability of BI 1595043 under fed state (Test, T) and under fasted state (Reference, R).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BI 1595043 | Single dose of 30 milligram (mg) BI 1595043 as film coated tablets (1x 5mg tablet and 1x 25mg tablet). |
Timeline
- Start date
- 2021-05-18
- Primary completion
- 2021-08-07
- Completion
- 2021-08-07
- First posted
- 2021-03-09
- Last updated
- 2024-02-22
- Results posted
- 2024-02-22
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT04789291. Inclusion in this directory is not an endorsement.